China Development Research Foundation   |  APP Download   |   中文   |   Register   |   Login
Time:March 23-25, 2019
Beijing Diaoyutai State Guesthouse
Sponsor:Development Research Center of the State Council
Organiser:China Development Research Foundation
CDF WeChat
CDRF WeChat
CDRF Weibo
Q&A
Chinese Delegates International Delegates Participating Organisations

Novartis Back Participating Organisations List>

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 130 000 people of nearly 150 nationalities work at Novartis around the world.


Novartis China
Novartis is committed to improving Chinese people’s health conditions and quality of life through its innovative products and services. More than a phonetic sound, the Chinese name for Novartis, Nuo Hua, means “commitment to China”.  Novartis’ operations in China include Novartis Oncology, Novartis Pharmaceuticals, Sandoz and Alcon, with three major production bases established in the country and two key R&D centers located in Shanghai and Jiangsu. Novartis comprehensively serves the health needs of the Chinese people through its diversified business portfolio that ranges from R&D to production and sales. Novartis currently employs more than 9,100 associates in China.